Candidate mechanisms for capecitabine-related hand–foot syndrome

AIMS: The oral fluoropyrimidine prodrug capecitabine is widely used in oncology. Capecitabine was designed to generate 5FU via the thymidine phosphorylase (TP) enzyme, preferentially expressed in tumoral tissues. Hand–foot syndrome (HFS) is a limiting toxicity of capecitabine. A pilot study on healt...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Milano, Gérard, Etienne-Grimaldi, Marie-Christine, Mari, Mireille, Lassalle, Sandra, Formento, Jean-Louis, Francoual, Mireille, Lacour, Jean-Philippe, Hofman, Paul
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2008
Matèries:
Drug Safety
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2485249/
https://ncbi.nlm.nih.gov/pubmed/18341672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2008.03159.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars